Bosnian drug maker Bosnalijek turns to profit in H1

SARAJEVO (Bosnia and Herzegovina), September 4 (SeeNews) – Bosnian pharmaceuticals maker Bosnalijek [SAJ:BSNLR] turned to a net profit of 4.55 million marka ($3.1 million/2.33 million euro) in the first half of 2014 from a net loss of 668,000 marka a year earlier, company data indicated.

Sales revenues rose 11.98% to 51.4 million marka through June, Bosnalijek said on its website.

(1 euro=1.95583 Bosnian marka)

5 / 5 free articles left this month
Get more for free. Sign up for Basic subscription
Get full access. Upgrade to Premium subscription